Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Redeye provides a research update following the Q1 report published by Alzinova earlier today.</li><li>The financials in the report contained no major surprises, being in line with our expectations.</li><li>Importantly, Alzinova’s scientific article based on clinical results from the Phase Ib study with ALZ-101 has now been accepted for publication.</li></ul>

Redeye provides a research update following the Q1 report published by Alzinova earlier today.The financials in the report contained no major surprises, being in line with our expectations.Importantly, Alzinova’s scientific article based on clinical results from the Phase Ib study with ALZ-101 has now been accepted for publication.

Alzinova (Q1 Review): Scientific validation and strategic optionality